FCGR3A and COVID-19: Although this increase was observed in CD8+ T cells and not in CD4+ T cells, the augmented population of CD16+ T cells in BALF from patients with severe COVID-19 was further substantiated by data mining of scRNA-seq (Figure 5H and I).